Back to results
US 2016/0243067 A1Published application
Controlled Release Dosage Form
AssigneeOsmotica Kereskedelmi Es Szolgaltato Kft
InventorsGlenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Alejandro A. AGUILAR, Claude E. WRIGHT
Life of this patent
Estimating the term…
Abstract
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
Claims30
1) A controlled release oral dosage form comprising:
- a) a core comprising at least one GABAB receptor agonist and at least one excipient;
- and
- b) a semipermeable membrane surrounding the core and comprising at least one preformed passageway.
Dependencies are inferred from the claim text.